Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review

BACKGROUND: Darunavir is a second-generation protease-inhibitor used with ritonavir (DRV/r) and two nucleoside reverse-transcriptase inhibitors as an option in first-line antiretroviral treatment (ART). METHODS: We systematically reviewed randomized controlled trials (RCTs) of DRV/r versus other reg...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:AIDS Res Treat
Hlavní autoři: Balayan, Tatevik, Horvath, Hacsi, Rutherford, George W.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2017
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5634582/
https://ncbi.nlm.nih.gov/pubmed/29082041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/2345617
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky